KR102316078B1 - Liquefaction method of rock and insoluble mineral using organic acid and oxygen catalyst - Google Patents
Liquefaction method of rock and insoluble mineral using organic acid and oxygen catalyst Download PDFInfo
- Publication number
- KR102316078B1 KR102316078B1 KR1020200008770A KR20200008770A KR102316078B1 KR 102316078 B1 KR102316078 B1 KR 102316078B1 KR 1020200008770 A KR1020200008770 A KR 1020200008770A KR 20200008770 A KR20200008770 A KR 20200008770A KR 102316078 B1 KR102316078 B1 KR 102316078B1
- Authority
- KR
- South Korea
- Prior art keywords
- administering
- stirring
- insoluble
- sodium percarbonate
- organic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 52
- 239000011707 mineral Substances 0.000 title claims abstract description 52
- 239000011435 rock Substances 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 28
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 17
- 239000001301 oxygen Substances 0.000 title claims abstract description 17
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 17
- 150000007524 organic acids Chemical class 0.000 title claims abstract description 16
- 239000003054 catalyst Substances 0.000 title claims abstract description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 72
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 50
- 239000000843 powder Substances 0.000 claims abstract description 36
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 claims abstract description 24
- 229940045872 sodium percarbonate Drugs 0.000 claims abstract description 24
- 239000008213 purified water Substances 0.000 claims abstract description 20
- 238000003756 stirring Methods 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 239000002244 precipitate Substances 0.000 claims abstract description 6
- 238000010438 heat treatment Methods 0.000 claims abstract description 5
- 239000011874 heated mixture Substances 0.000 claims abstract description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 4
- 238000011049 filling Methods 0.000 claims abstract description 4
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 claims abstract description 4
- 239000010438 granite Substances 0.000 claims description 7
- 235000014653 Carica parviflora Nutrition 0.000 claims description 5
- 241000243321 Cnidaria Species 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 239000010450 olivine Substances 0.000 claims description 4
- 229910052609 olivine Inorganic materials 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- 229910021536 Zeolite Inorganic materials 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052732 germanium Inorganic materials 0.000 claims description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 3
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims description 3
- 229910052900 illite Inorganic materials 0.000 claims description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 3
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- -1 sunjit Substances 0.000 claims description 3
- 229910052613 tourmaline Inorganic materials 0.000 claims description 3
- 239000011032 tourmaline Substances 0.000 claims description 3
- 229940070527 tourmaline Drugs 0.000 claims description 3
- 239000010457 zeolite Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 239000013049 sediment Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 18
- 239000000126 substance Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- JYIBXUUINYLWLR-UHFFFAOYSA-N aluminum;calcium;potassium;silicon;sodium;trihydrate Chemical compound O.O.O.[Na].[Al].[Si].[K].[Ca] JYIBXUUINYLWLR-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910001603 clinoptilolite Inorganic materials 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 238000000504 luminescence detection Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K5/00—Heat-transfer, heat-exchange or heat-storage materials, e.g. refrigerants; Materials for the production of heat or cold by chemical reactions other than by combustion
- C09K5/08—Materials not undergoing a change of physical state when used
- C09K5/10—Liquid materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Water Supply & Treatment (AREA)
- Hydrology & Water Resources (AREA)
- Combustion & Propulsion (AREA)
- Physical Education & Sports Medicine (AREA)
- Materials Engineering (AREA)
- Environmental & Geological Engineering (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
본 발명은 유기산과 산소 촉매를 이용하는 암석과 불용성 미네랄의 액상화 방법에 관한 것으로 더욱 상세하게는 인체 친화적인 유기산과 쉽게 구할 수 있는 과탄산소다를 산소촉매로 이용하는 방법에 관한 것이다.
이는 20ℓ 용기에 정제수 10ℓ를 채우고 구연산 2kg를 넣는 단계; 상기 구연산이 삽입된 정제수를 80℃로 가열하면서 교반하고, 정제수에 500메시(mesh) 이상으로 가공된 암석분말 50g을 투여하는 단계; 상기 암석분말을 투여한 후 80℃로 유지하면서 과탄산소다 200g을 1시간 동안 여러 번에 걸쳐 투여하고, 교반하는 과탄산소다 투여 단계; 최종 과탄산소다를 투여한 후 1시간 동안 80℃를 유지하면서 교반하는 최종 혼합 단계; 상기 가열된 혼합물을 필터로 여과하여 침전물을 제거하는 과정을 통해 제1 미네랄 용액을 추출하는 단계;를 포함한다.The present invention relates to a method for liquefying rocks and insoluble minerals using an organic acid and an oxygen catalyst, and more particularly, to a method using a human-friendly organic acid and easily available sodium percarbonate as an oxygen catalyst.
This includes the steps of filling a 20L container with 10L of purified water and putting 2kg of citric acid; Stirring the purified water into which the citric acid has been inserted to 80° C. while heating, and administering 50 g of the rock powder processed to 500 mesh or more to the purified water; Soda percarbonate administration step of administering 200 g of sodium percarbonate several times for 1 hour while maintaining the temperature at 80 ° C after administering the rock powder, and stirring; a final mixing step of stirring while maintaining 80° C. for 1 hour after the final administration of sodium percarbonate; and extracting the first mineral solution through a process of filtering the heated mixture through a filter to remove the precipitate.
Description
본 발명은 유기산과 산소 촉매를 이용하는 암석과 불용성 미네랄의 액상화 방법에 관한 것으로 더욱 상세하게는 인체 친화적인 유기산과 쉽게 구할 수 있는 과탄산소다를 산소촉매로 이용하여 생리활성을 촉진하는 암석분말과 수용성으로 만들기 힘든 미네랄을 액상화하는 방법에 관한 것이다.The present invention relates to a method for liquefying rocks and insoluble minerals using organic acids and oxygen catalysts. It is about a method of liquefying minerals that are difficult to make.
최근 물의 구조 이론에서 미국의 폴락에 의해서 EZ(Exclusion Zone)이론이 세계적으로 인정받고 있다. Recently, the EZ (Exclusion Zone) theory has been recognized worldwide by Pollock of the United States in the theory of the structure of water.
EZ이론에 의하면 친수성의 표면에서 물이 자유전자가 포함된 치밀한 구조를 이루고 상대적으로 자유로운 물은 EZ 밖에 배치되게 된다. According to the EZ theory, water forms a dense structure including free electrons on the hydrophilic surface, and relatively free water is placed outside the EZ.
EZ이론은 여태까지 이해하기 힘들었던 물의 신비한 능력들을 모두 설명하고 있다.(Pollack, J, The 4th phase of water) 물의 치밀한 구조는 국내에서는 전무식에 의해서 6각수 이론으로 설명되었으나(전무식, 6각수의 수수께끼), 6각수 이론은 컴퓨터모델링에 의해서 제안되었을 뿐이다.The EZ theory explains all the mysterious abilities of water that have been difficult to understand so far (Pollack, J, The 4 th phase of water). Although the dense structure of water has been explained by the hexagonal theory by enigma), the hexagonal number theory has only been proposed by computer modeling.
일본의 카와다 카오루는 화강암, 현무암, 감람암을 황산으로 액상으로 추출하였을 때, 화강암은 동식물의 성장을 촉진하는 강한 생리활성을 보였고, 현무암은 물에 잘 녹지 않기 어려운 물질을 녹이는 계면활성이 뛰어나고, 감람암의 경우 수질정화작용을 하는 것을 발견했다. When Kaoru Kawada of Japan extracted granite, basalt, and olivine in liquid form with sulfuric acid, granite showed strong physiological activity that promotes the growth of animals and plants, and basalt has excellent surface activity to dissolve substances that are difficult to dissolve in water, and olivine. was found to have a water purification effect.
하지만 이 3가지 미네랄 용액의 성분을 분석해 보았을 때 모두 비슷한 조성을 갖고 있었다. 이것은 암석에 따라 나타나는 성질이 암석의 원소조성에 의한 것이 아니라 암석의 기본구조 그 자체에 의한 것이라는 것을 의미한다. However, when the components of these three mineral solutions were analyzed, they all had a similar composition. This means that the properties that appear depending on the rock are not due to the elemental composition of the rock, but to the basic structure of the rock itself.
다시 말하면 암석이 용액의 상태가 되더라도 미네랄의 기본구조는 변하지 않은 상태에서 촉매로 작용하는 것이다. In other words, even if the rock becomes a solution, the basic structure of the mineral remains unchanged and acts as a catalyst.
암석의 구성성분인 실리카는 규소(Si)를 핵으로 하고 각 꼭지점에 산소가 있는 정사면체의 기본 골격을 갖고 있으며 이러한 구조골격의 배열에 따라 다양한 암석이 형성된다. Silica, a component of rock, has a basic skeleton of a tetrahedron with silicon (Si) as the nucleus and oxygen at each vertex, and various rocks are formed according to the arrangement of these structural skeletons.
이러한 구조를 갖는 미네랄들은 5 나노미터(nm) 이하의 작은 크기에서 촉매능력을 갖는데 단순한 원소상태의 미네랄에 비해서 무려 1만 배에서 10만 배까지 촉매능력이 증가하는 것이 알려졌다 (김현원, 생명의 물, 기적의 물). 그리고 액상화된 실리카는 물속에서 수도 없이 많은 친수성 표면을 제공하며 EZ 즉, 6각수를 만들 수 있게 된다. Minerals with this structure have catalytic capacity at a small size of 5 nanometers (nm) or less, and it is known that the catalytic capacity increases by 10,000 to 100,000 times compared to simple elemental minerals (Hyeonwon Kim, Water of Life) , miracle water). And liquefied silica provides countless hydrophilic surfaces in water, making it possible to make EZ, that is, hexagonal water.
카와다는 암석의 분말을 황산을 이용해서 액상화하였다. 액상 암석미네랄을 농업현장에서 사용해본 결과 무농약농법도 가능할 정도로 병충해를 물리칠 수 있었으며, 식물의 성장이 촉진되며, 열매가 충실해졌다고 한다. Kawada liquefied the rock powder using sulfuric acid. As a result of using the liquid rock mineral in the agricultural field, it is said that the pesticide-free farming method was able to repel pests and diseases, the growth of plants was promoted, and the fruits were enriched.
수산양식현장에서도 살균능력이 뛰어날 뿐 아니라 물고기 배설물 등의 유기물질이 제거되기 때문에 물고기가 건강하게 빠른 속도로 자라고, 물고기의 질병이 치료되는 효과까지 나타났다. In the aquaculture field, not only the sterilization ability is excellent, but also the organic substances such as fish excrement are removed, so that the fish grows at a fast speed and healthy, and it has the effect of curing the disease of the fish.
암석을 액상화할 때 암석은 나노미터 사이즈로 변하게 되며 촉매작용을 할 수 있게 되며, 암석에 다량으로 존재하는 친수성의 실리카를 담은 물은 치밀한 구조의 EZ를 형성하게 된다. 하지만 강산으로 암석을 액상으로 만들게 되면 인체용으로 사용이 불가능하다. When a rock is liquefied, the rock changes to a nanometer size and can catalyze, and the water containing hydrophilic silica present in a large amount in the rock forms an EZ with a dense structure. However, if the rock is made into a liquid with strong acid, it cannot be used for human use.
본 발명은 상기와 같은 문제점을 해결하기 위하여 인체 친화적인 유기산과 쉽게 구할 수 있는 과탄산소다를 산소촉매로 이용하여 생리활성을 촉진하는 암석분말과 수용성으로 만들기 힘든 미네랄을 액상화하는 방법을 제공하는 데에 그 목적이 있다.In order to solve the above problems, the present invention provides a method of liquefying a mineral that is difficult to make water-soluble and a rock powder that promotes physiological activity by using a human-friendly organic acid and easily available sodium percarbonate as an oxygen catalyst. has its purpose in
상기와 같은 목적을 달성하기 위하여 본 발명은 20ℓ 용기에 정제수 10ℓ를 채우고 구연산 2kg를 넣는 단계; 상기 구연산이 삽입된 정제수를 80℃로 가열하면서 교반하고, 정제수에 500메시(mesh) 이상으로 가공된 암석분말 50g을 투여하는 단계; 상기 암석분말을 투여한 후 80℃로 유지하면서 과탄산소다 200g을 1시간 동안 여러 번에 걸쳐 투여하고, 교반하는 과탄산소다 투여 단계; 최종 과탄산소다를 투여한 후 1시간 동안 80℃를 유지하면서 교반하는 최종 혼합 단계; 상기 가열된 혼합물을 필터로 여과하여 침전물을 제거하는 과정을 통해 제1 미네랄 용액을 추출하는 단계;를 포함한다.In order to achieve the above object, the present invention comprises the steps of filling a 20ℓ container with 10ℓ of purified water and putting 2 kg of citric acid; stirring the purified water into which the citric acid has been inserted to 80° C. while stirring, and administering 50 g of the rock powder processed to 500 mesh or more to the purified water; Soda percarbonate administration step of administering 200 g of sodium percarbonate several times for 1 hour while maintaining the temperature at 80 ° C after administering the rock powder, and stirring; a final mixing step of stirring while maintaining 80° C. for 1 hour after the final administration of sodium percarbonate; and extracting the first mineral solution through a process of filtering the heated mixture through a filter to remove the precipitate.
또한, 본 발명의 다른 방법은, 20ℓ용기에 제1항에서 얻어진 제1 미네랄 용액을 10배 희석하여 10ℓ를 채우고 구연산 2kg를 넣는 단계; 상기 구연산이 투여된 제1 미네랄 용액을 80℃로 가열 및 교반하면서 500메시(mesh) 이상의 가공된 불용성분말 100g을 투여하는 단계; 상기 불용성분말을 투여한 후 80℃를 유지하면서 과탄산소다 200g을 1시간 동안 여러 번에 걸쳐 교반하면서 투여하는 과탄산소다 투여 단계; 최종 과탄산소다를 투여한 후 1시간 동안 80℃를 유지하면서 교반하는 최종 혼합 단계; 상기 가열된 혼합물을 필터로 여과하여 침전물이 제거하는 과정을 통해 제2 미네랄 용액을 추출하는 단계;를 포함한다.In addition, another method of the present invention, the step of diluting 10 times the first mineral solution obtained in claim 1 in a 20ℓ container to fill 10ℓ and put 2kg of citric acid; administering 100 g of processed insoluble powder of 500 mesh or more while heating and stirring the first mineral solution to which the citric acid is administered to 80° C.; Soda percarbonate administration step of administering 200g of sodium percarbonate while stirring several times for 1 hour while maintaining 80 ℃ after administering the insoluble powder; a final mixing step of stirring while maintaining 80° C. for 1 hour after the final administration of sodium percarbonate; and extracting the second mineral solution through a process of filtering the heated mixture through a filter to remove the precipitate.
상기와 같은 본 발명은 인체 친화적인 유기산과 쉽게 구할 수 있는 과탄산소다를 산소촉매로 이용하여 생리활성을 촉진하는 암석분말과 수용성으로 만들기 힘든 미네랄을 액상화하는 것이다.The present invention as described above is to liquefy rock powder that promotes physiological activity and minerals that are difficult to make water-soluble by using human-friendly organic acids and readily available sodium percarbonate as oxygen catalysts.
도 1~2는 본 발명에 따른 액상화 방법의 순서도1-2 is a flowchart of a liquefaction method according to the present invention;
이하에서 본 발명의 바람직한 실시를 위한 구체적인 내용을 첨부된 도면에 의하여 상세히 설명하면 다음과 같다.Hereinafter, specific details for preferred implementation of the present invention will be described in detail with reference to the accompanying drawings.
본 발명인 유기산과 산소 촉매를 이용하는 암석과 불용성 미네랄의 액상화 방법은 구연산 투입 단계, 암석분말 투여 단계, 과탄산소다 투여 단계, 최종 혼합 단계, 제1 미네랄 용액 추출 단계로 이루어진다.The liquefaction method of rocks and insoluble minerals using an organic acid and an oxygen catalyst according to the present invention comprises a citric acid input step, a rock powder administration step, a sodium percarbonate administration step, a final mixing step, and a first mineral solution extraction step.
상기 구연산 투입 단계는,The citric acid input step,
20ℓ용기에 정제수를 10ℓ채우고, 용기 내부에 유기산인 구연산(시트르산) 2kg를 넣는다.
상기 정제수는 역삼투압 정수기를 통과해서 이물질과 미네랄이 제거된 물이다. Fill a 20ℓ container with 10ℓ of purified water, and put 2kg of citric acid (citric acid), an organic acid, inside the container.
The purified water is water from which foreign substances and minerals are removed by passing through a reverse osmosis water purifier.
상기 구연산은 산의 일종으로 산화를 막는 천연방부제의 기능 및 신맛을 가지고 있으며, 항산화, 항염 작용과 미네랄 성분들의 흡수율을 높여주는 기능을 한다.The citric acid is a kind of acid and has the function of a natural preservative to prevent oxidation and sour taste, and functions to increase the absorption rate of the mineral components as well as the antioxidant, anti-inflammatory action.
또한, 구연산은 기본적으로 산성물질이지만 소화과정을 거쳐 알칼리로 전환되어 작용하기 때문에 산성화된 몸을 중화시키는 효능이 있다.In addition, although citric acid is basically an acidic substance, it has the effect of neutralizing the acidified body because it is converted to alkali through the digestive process.
상기 구연산(유기산)은 물에 녹지 않는 미네랄 성분을 용출시키는 능력이 탁월하며, 광물에 포함된 물에 녹지 않는 미네랄 성분들은 유기산이 촉매로 사용될 경우 용출효율이 증대될 수 있다.The citric acid (organic acid) has an excellent ability to elute insoluble mineral components in water, and the water insoluble mineral components contained in minerals can increase the elution efficiency when an organic acid is used as a catalyst.
상기 암석분말 투여 단계는,The step of administering the rock powder,
상기 구연산이 삽입된 정제수를 80℃로 가열하면서 교반기를 이용하여 교반하면서 500메시(mesh) 이상으로 가공된 암석분말 50g을 투여한다.While heating the purified water into which the citric acid has been inserted to 80° C. and stirring it using a stirrer, 50 g of the rock powder processed to a size of 500 mesh or more is administered.
상기 암석분말은 화강암을 분쇄하여 분말로 가공한 것이며, 가열된 정제수 속에 투입된 구연산과 서로 섞이게 되고, 구연산은 열에 의해 증기를 발생하면서 탄화된다.The rock powder is granite pulverized and processed into powder, mixed with citric acid injected into heated purified water, and the citric acid is carbonized while generating steam by heat.
암석분말에 사용하는 암석은 화강암, 현무암, 귀사문석, 일라이트, 순지트, 제올라이트, 전기석, 자철석, 감람암 중 적어도 어느 하나를 사용할 수 있으며, 그 밖에 다양한 암석들을 부가하여 사용할 수도 있다.At least one of granite, basalt, serpentine, illite, sunjit, zeolite, tourmaline, magnetite, and olivine may be used as the rock used for the rock powder, and various other rocks may be added.
상기 화강암(Granite)은 풍부한 미네랄을 함유하고 있고, 현무암(Basalt)은 풍부한 미네랄과 칼슘을 함유하고 있다.The granite contains abundant minerals, and basalt contains abundant minerals and calcium.
귀사문석(Prious Serpentine)은 마그네슘, 칼륨, 나트륨, 칼슘, 철분, 규소 등 인체에 유익한 성분이 풍부하게 들어있어 원적외선 방사율이 높고 옥보다 기(氣)가 3배 이상 많다.Prious Serpentine is rich in ingredients beneficial to the human body, such as magnesium, potassium, sodium, calcium, iron, and silicon, and has a high far-infrared emissivity and three times more energy than jade.
일라이트(견운모, Illite)는 음이온 발생과 원적외선 방사 및 공기 정화 등 다양한 기능을 한다. Illite (sericite) has various functions such as generating negative ions, radiating far-infrared rays, and purifying air.
순지트(Shungite)는 천연 산화방지제로써 수많은 질병에 대한 인간의 면역성을 높여주는 기능을 하며, 물과 공기를 정화시키는 기능을 한다.Shungite is a natural antioxidant that enhances human immunity against numerous diseases and purifies water and air.
제올라이트(Clinoptilolite)는 미네랄을 다량으로 분출하며, 인체의 독소를 효과적으로 제거한다고 알려져 있다.Zeolite (Clinoptilolite) is known to release a large amount of minerals and effectively remove toxins from the body.
전기석(Tourmaline)은 물에 미세전류를 발생하여 물에 환원력을 부여하고, 음이온을 발생해주며, 혈류속도를 증가시켜주며, 통증을 제거해주며, 물질의 파동을 잘 기억하는 성질을 갖고 있다.Tourmaline generates a microcurrent in water to give water a reducing power, generates negative ions, increases blood flow rate, removes pain, and has the property of remembering the wave of substances well.
자철석(Magnetite)은 자성을 띠면서 물질의 파동을 잘 기억하는 성질을 갖고 있다. 감람암(Periotite)은 수질을 정화하는 용도로 사용되고 있다. Magnetite is magnetic and has the property of remembering the wave of matter well. Periotite is used to purify water.
상기 과탄산소다 투여 단계는,In the step of administering sodium percarbonate,
상기 미립의 암석분말이 녹아있는 정제수를 80℃를 유지하면서 가열한다. 그리고 가열된 정제수 속에 산화제인 과탄산소다 200g을 1시간 동안에 여러 번에 걸쳐 투여하면서 교반한다. The purified water in which the fine rock powder is dissolved is heated while maintaining 80°C. Then, 200 g of sodium percarbonate, an oxidizing agent, is administered in heated purified water several times during 1 hour while stirring.
상기 최종 혼합 단계는,The final mixing step is
상기 용기 내부에 최종 과탄산소다를 투여한 후 1시간 동안 80℃를 유지하면서 교반한다.After administration of the final sodium percarbonate into the container, the mixture is stirred while maintaining 80° C. for 1 hour.
상기 과탄산소다는 정제수에 녹으면서 물과 산소로 분해하면서 촉매 반응으로 산화한다. The sodium percarbonate is oxidized by a catalytic reaction while being dissolved in purified water and decomposed into water and oxygen.
상기 제1 미네랄 용액 추출 단계는,The first mineral solution extraction step,
상기 용기 내부에서 가열된 혼합물을 필터로 여과하여 침전물을 제거하는 과정을 통하여 제1 미네랄 용액을 추출한다. 상기 제1 미네랄 용액은 PH(수소이온 지수)는 4 정도이며, 원하는 농도로 희석하여 사용할 수 있다.The first mineral solution is extracted through the process of removing the precipitate by filtering the mixture heated in the container with a filter. The first mineral solution has a PH (hydrogen ion index) of about 4, and may be diluted to a desired concentration.
상기와 같은 본 발명의 다른 실시 예를 설명하면 다음과 같다.Another embodiment of the present invention as described above will be described as follows.
상기 암석분말 이외의 산호분말, 마그네슘, 아연, 게르마늄, 은 등 수용성으로 만들기 힘든 불용성 미네랄도 액상화할 수 있으며, 불용성 분말을 액상화하는 방법을 설명하면 다음과 같다.Insoluble minerals that are difficult to make water-soluble such as coral powder, magnesium, zinc, germanium, and silver other than the rock powder can be liquefied, and the method of liquefying the insoluble powder is as follows.
본 발명인 유기산과 산소 촉매를 이용하는 불용성 미네랄의 액상화 방법은 구연산 투입 단계, 불용성분말 투여 단계, 과탄산소다 투여 단계, 최종 혼합 단계, 제1 미네랄 용액 추출 단계로 이루어진다.The method for liquefying insoluble minerals using an organic acid and oxygen catalyst according to the present invention consists of a citric acid input step, an insoluble powder administration step, a sodium percarbonate administration step, a final mixing step, and a first mineral solution extraction step.
상기 구연산 투입 단계는,The citric acid input step,
20ℓ용기에 제1 미네랄 용액을 10배 희석하여 10ℓ를 채우고 구연산 2kg를 넣는다.Dilute the first mineral solution 10 times in a 20ℓ container, fill 10ℓ, and add 2kg of citric acid.
상기 불용성분말 투여 단계는,The step of administering the insoluble powder,
상기 구연산이 삽입된 정제수를 80℃로 가열하면서 교반기를 이용하여 교반하면서 500메시(mesh) 이상으로 가공된 불용성 분말 100g을 투여한다.
상기 정제수는 역삼투압 정수기를 통과해서 이물질과 미네랄이 제거된 물이다. 100 g of insoluble powder processed to 500 mesh or more is administered while the purified water having the citric acid inserted is heated to 80° C. while stirring using a stirrer.
The purified water is water from which foreign substances and minerals are removed by passing through a reverse osmosis water purifier.
상기 불용성분말은 산호분말을 분쇄하여 분말로 가공한 것이며, 가열된 정제수 속에 투입된 구연산과 서로 섞이게 되고, 구연산은 열에 의해 증기를 발생하면서 탄화된다.The insoluble powder is processed into powder by pulverizing coral powder, and is mixed with citric acid put in heated purified water, and the citric acid is carbonized while generating steam by heat.
상기 불용성분말로 사용하는 물질은 산호분말, 마그네슘, 아연, 게르마늄, 은, 금을 분말로 분쇄하여 사용한다.The material used as the insoluble powder is used by pulverizing coral powder, magnesium, zinc, germanium, silver, and gold into a powder.
상기 산호는 석회질(칼슘)과 75가지의 미네랄 물질을 포함하는 미네랄 덩어리이며, 유기칼슘으로 물에 닿으면 바로 이온화되는 특성이 있으며, 인체 흡수율이 70%로 여타의 칼슘보다 흡수율이 높다.The coral is a mineral mass containing calcareous (calcium) and 75 kinds of mineral substances, and has the property of being ionized immediately when it comes into contact with water as organic calcium, and the absorption rate of the human body is 70%, which is higher than other calcium.
상기 과탄산소다 투여 단계는, In the step of administering sodium percarbonate,
상기 용기 내부에 불용성 분말을 투여한 후 80℃를 유지하면서 과탄산소다 200g을 1시간 동안 여러 번에 걸쳐 투여하면서 교반한다.After administering the insoluble powder into the container, while maintaining 80° C., 200 g of sodium percarbonate is administered several times for 1 hour while stirring.
상기 최종 혼합 단계는,The final mixing step is
상기 용기 내부에 최종 과탄산소다를 투여한 후 1시간 동안 80℃를 유지하면서 교반한다.After administration of the final sodium percarbonate into the container, the mixture is stirred while maintaining 80° C. for 1 hour.
상기 과탄산소다는 정제수에 녹으면서 물과 산소로 분해하면서 촉매 반응으로 산화한다. The sodium percarbonate is oxidized by a catalytic reaction while being dissolved in purified water and decomposed into water and oxygen.
상기 제2 미네랄용액 추출 단계는,The second mineral solution extraction step,
상기 용기 내부에서 가열된 혼합물을 필터로 여과하여 침전물을 제거하는 과정을 통하여 제2 미네랄용액을 추출한다. 상기 제2 미네랄 용액은 PH(수소이온 지수)는 4 정도이며, 원하는 농도로 희석하여 사용할 수 있다.The second mineral solution is extracted through the process of removing the precipitate by filtering the mixture heated in the container with a filter. The second mineral solution has a PH (hydrogen ion index) of about 4, and may be diluted to a desired concentration.
이하, 본 발명에 따른 용도를 설명하면 다음과 같다.Hereinafter, the use according to the present invention will be described as follows.
①EZ 구조의 물 생성 용도①Use of EZ structure for water generation
상기 본 발명의 방법으로 만든 제1, 2 미네랄용액을 혼합하여 다음의 성분의 미네랄용액을 만들었다. 편의상 이 용액을 유락이라고 명명하고, 본 발명의 본문에서 유락이라고 표현한다. 유락의 성분은 서울대 농생명과학대학 공동기기센터의 발광분광분석장치(ICP-AES)를 이용하여 분석하였다. The first and second mineral solutions prepared by the method of the present invention were mixed to prepare a mineral solution of the following components. For convenience, this solution is named Yurak, and is expressed as Yurak in the text of the present invention. The components of milk lacquer were analyzed using the luminescence spectroscopy (ICP-AES) of the Joint Instrumentation Center of the College of Agriculture and Life Sciences, Seoul National University.
유락을 10배 희석한 후, 17O NMR과 280nm에서 흡광도를 측정(표 2 참조)하였다. 17O NMR 산소피크의 반치폭은 물의 클러스터의 크기를 말해주고, 280nm에서의 흡광도는 물이 얼마나 EZ구조를 형성하는가를 의미한다. 이 결과는 유락에 의해서 EZ 구조의 물 만들어짐을 의미한다. After diluting the oil 10 times , the absorbance was measured at 17 O NMR and 280 nm (see Table 2). The half width of the 17 O NMR oxygen peak tells the size of the cluster of water, and the absorbance at 280 nm means how much water forms the EZ structure. This result means that EZ-structured water is created by drift.
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
Claims (5)
상기 구연산이 삽입된 정제수를 80℃로 가열하면서 교반하고, 정제수에 500메시(mesh) 이상으로 가공된 암석분말 50g을 투여하는 단계;
상기 암석분말을 투여한 후 80℃로 유지하면서 과탄산소다 200g을 1시간 동안 여러 번에 걸쳐 투여하고, 교반하는 과탄산소다 투여 단계;
최종 과탄산소다를 투여한 후 1시간 동안 80℃를 유지하면서 교반하는 최종 혼합 단계;
상기 가열된 혼합물을 필터로 여과하여 침전물을 제거하는 과정을 통해 제1 미네랄 용액을 추출하는 단계;를 포함하는 유기산과 산소 촉매를 이용하는 암석과 불용성 미네랄의 액상화 방법.Filling a 20L container with 10L of purified water and putting 2kg of citric acid;
Stirring the purified water into which the citric acid has been inserted to 80° C. while heating, and administering 50 g of the rock powder processed to 500 mesh or more to the purified water;
Soda percarbonate administration step of administering 200 g of sodium percarbonate several times for 1 hour while maintaining the temperature at 80 ° C after administering the rock powder, and stirring;
a final mixing step of stirring while maintaining 80° C. for 1 hour after the final administration of sodium percarbonate;
A method of liquefying rocks and insoluble minerals using an organic acid and an oxygen catalyst, comprising: extracting a first mineral solution through a process of removing precipitates by filtering the heated mixture through a filter.
상기 암석분말은 화강암, 귀사문석, 일라이트, 순지트, 제올라이트, 현무암, 전기석, 자철석, 감람암 중 어느 하나인 것을 포함하는 유기산과 산소 촉매를 이용하는 암석과 불용성 미네랄의 액상화 방법.According to claim 1,
The rock powder is a liquefaction method of a rock and an insoluble mineral using an organic acid and an oxygen catalyst, including any one of granite, serpentine, illite, sunjit, zeolite, basalt, tourmaline, magnetite, and olivine.
상기 구연산이 투여된 제1 미네랄 용액을 80℃로 가열 및 교반하면서 500메시(mesh) 이상의 가공된 불용성분말 100g을 투여하는 단계;
상기 불용성분말을 투여한 후 80℃를 유지하면서 과탄산소다 200g을 1시간 동안 여러 번에 걸쳐 교반하면서 투여하는 과탄산소다 투여 단계;
최종 과탄산소다를 투여한 후 1시간 동안 80℃를 유지하면서 교반하는 최종 혼합 단계;
상기 가열된 혼합물을 필터로 여과하여 침전물이 제거하는 과정을 통해 제2 미네랄 용액을 추출하는 단계;를 포함하는 유기산과 산소 촉매를 이용하는 암석과 불용성 미네랄의 액상화 방법.The step of diluting the first mineral solution obtained in claim 1 10 times in a 20ℓ container, filling 10ℓ, and putting 2 kg of citric acid;
administering 100 g of processed insoluble powder of 500 mesh or more while heating and stirring the first mineral solution to which the citric acid is administered to 80° C.;
a sodium percarbonate administration step of administering 200 g of sodium percarbonate while stirring several times for 1 hour while maintaining 80° C. after administering the insoluble powder;
a final mixing step of stirring while maintaining 80° C. for 1 hour after the final administration of sodium percarbonate;
A method of liquefying rocks and insoluble minerals using an organic acid and an oxygen catalyst, comprising: filtering the heated mixture through a filter and extracting a second mineral solution through a process of removing sediment.
상기 불용성분말은 산호분말, 마그네슘, 아연, 게르마늄, 은 중 어느 하나인 것을 포함하는 유기산과 산소 촉매를 이용하는 암석과 불용성 미네랄의 액상화 방법. 4. The method of claim 3,
The method for liquefying rocks and insoluble minerals using an organic acid and an oxygen catalyst, wherein the insoluble powder includes any one of coral powder, magnesium, zinc, germanium, and silver.
상기 제1,2 미네랄 용액은 PH(수소이온 지수) 4인 것을 포함하는 유기산과 산소 촉매를 이용하는 암석과 불용성 미네랄의 액상화 방법.4. The method of claim 3,
The liquefaction method of rocks and insoluble minerals using an organic acid and an oxygen catalyst comprising the first and second mineral solutions having a PH (hydrogen ion index) of 4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200008770A KR102316078B1 (en) | 2020-01-22 | 2020-01-22 | Liquefaction method of rock and insoluble mineral using organic acid and oxygen catalyst |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200008770A KR102316078B1 (en) | 2020-01-22 | 2020-01-22 | Liquefaction method of rock and insoluble mineral using organic acid and oxygen catalyst |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210095285A KR20210095285A (en) | 2021-08-02 |
KR102316078B1 true KR102316078B1 (en) | 2021-10-25 |
Family
ID=77315524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200008770A Active KR102316078B1 (en) | 2020-01-22 | 2020-01-22 | Liquefaction method of rock and insoluble mineral using organic acid and oxygen catalyst |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102316078B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102528145B1 (en) | 2022-05-25 | 2023-05-03 | 미온바이오 주식회사 | Method to produce bio-mineral beverage which is helpful for Diabetes |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102666827B1 (en) * | 2023-03-29 | 2024-05-17 | 김유림 | Composition for water purifying, water purifying method using the same and water purifying device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101239540B1 (en) | 2010-12-24 | 2013-03-06 | 박노연 | Method of maunfacturing mineral water for plant growth promoting and method of using thereof |
KR101449320B1 (en) | 2013-08-12 | 2014-10-08 | 주식회사 옴니시스템바이오 | Manufacturing method of chelated organic mineral in deposition and separation process |
KR101873931B1 (en) | 2017-10-10 | 2018-08-03 | 김승기 | Manufacturing method for functional mineral water of ionized calcium using natural material |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0648705A (en) * | 1992-07-28 | 1994-02-22 | Mitsubishi Rayon Co Ltd | Oxygen-generating agent |
KR20170084630A (en) | 2016-01-12 | 2017-07-20 | 남승우 | The Manufactural Method For The Beverage Composite With Natural Minerals |
-
2020
- 2020-01-22 KR KR1020200008770A patent/KR102316078B1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101239540B1 (en) | 2010-12-24 | 2013-03-06 | 박노연 | Method of maunfacturing mineral water for plant growth promoting and method of using thereof |
KR101449320B1 (en) | 2013-08-12 | 2014-10-08 | 주식회사 옴니시스템바이오 | Manufacturing method of chelated organic mineral in deposition and separation process |
KR101873931B1 (en) | 2017-10-10 | 2018-08-03 | 김승기 | Manufacturing method for functional mineral water of ionized calcium using natural material |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102528145B1 (en) | 2022-05-25 | 2023-05-03 | 미온바이오 주식회사 | Method to produce bio-mineral beverage which is helpful for Diabetes |
WO2023229304A1 (en) * | 2022-05-25 | 2023-11-30 | 미온바이오 주식회사 | Method for producing therapeutically beneficial bio-mineral water for diabetes |
Also Published As
Publication number | Publication date |
---|---|
KR20210095285A (en) | 2021-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103204734B (en) | Nanometer rare earth selenium silicon titanium macro-trace element composite nutrition fertilizer | |
KR101873931B1 (en) | Manufacturing method for functional mineral water of ionized calcium using natural material | |
CN104071861A (en) | Sewage purifying agent and preparation method thereof | |
KR102316078B1 (en) | Liquefaction method of rock and insoluble mineral using organic acid and oxygen catalyst | |
CN103789114A (en) | Selenium-doped nano silica sol used for producing selenium-enriched rice and capable of suppressing absorption and accumulation of heavy metals in paddy rice and preparation method for selenium-doped nano silica sol | |
CN111972435A (en) | Preparation method of nano-silver-graphene oxide composite material | |
KR100643047B1 (en) | Manufacturing method of active solution containing a large amount of mineral | |
CN106219720A (en) | Improve composite mineral substance crystal of water quality, enhancing immunity, useful cardiovascular and cerebrovascular disease and preparation method thereof | |
KR20170065851A (en) | Efficient manufacturing method of mineral complex using natural ores and clays | |
CN103880511A (en) | Green agricultural element compound fertilizer | |
KR100922719B1 (en) | Method for producing mineral functional water, mineral functional water produced thereby | |
JP2008161864A (en) | Manufacturing method of far infrared ray radiant wave water, and far-infrared radiant wave water | |
CN107649498B (en) | Method for inhibiting plants from absorbing soil fluorine by using activated sludge modified clay mineral | |
KR101839706B1 (en) | manufacturing method of liquid fertilizer | |
KR100793815B1 (en) | How to get rid of sulfur toxicity | |
KR100777064B1 (en) | Manufacturing method of beauty massage pack containing natural mineral | |
KR20120120523A (en) | Minerals aqueous solution and its manufacturing method | |
CN102583868A (en) | Energy filter tube with message memory | |
KR102437895B1 (en) | A method for manufacturing of ionized calcium | |
CN104671298A (en) | Sepiolite oxygen-enriched activated water treatment agent | |
JP5250814B2 (en) | Production method of organic fertilizer from fishery processing residue | |
CN104473963B (en) | The preparation method of rare earth chemistry medicine lanthanum carbonate chewable tablets | |
Rathi et al. | A critical study of Gandhaka Shodhana | |
CN107961363A (en) | A kind of oyster shell whiting nano-antibacterial lavipeditum effervescent tablet and preparation method thereof | |
CN106309490A (en) | Active physiotherapy ring and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20200122 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20210726 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20211016 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20211018 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20211018 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20250414 Start annual number: 4 End annual number: 4 |